Roberts Brigette
SEC insider (Form 3/4/5 filer). CIK 0001346566. Chief Corp. Affairs Officer at Quince Therapeutics, Inc. (QNCX). 9 reported Form 4/5 transactions since Sep 2024; latest on May 18, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Roberts Brigette has filed insider reports for
- Quince Therapeutics, Inc. (QNCX): Director, Officer, Chief Corp. Affairs Officer
Roberts Brigette
CIK: 0001346566
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quince Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
34.7K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
228.9K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
124.8K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
69.4K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
362.1K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
133.6K shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
2.1M shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
6.8M shares- - May 18, 2026QNCX
Quince Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
6.8M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 34,675 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 228,855 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 124,830 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 69,350 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 362,092 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 133,615 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 2,070,107 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 6,837,319 | - | - | Direct |
| May 18, 2026 | QNCX Quince Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 6,837,319 | - | - | Direct |
1-9 of 9 transactions